Joe Taube
Joe Taube
Associate Professor of Biology, Baylor University
Verified email at - Homepage
Cited by
Cited by
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes
JH Taube, JI Herschkowitz, K Komurov, AY Zhou, S Gupta, J Yang, ...
Proceedings of the National Academy of Sciences 107 (35), 15449-15454, 2010
FOXC2 expression links epithelial–mesenchymal transition and stem cell properties in breast cancer
BG Hollier, AA Tinnirello, SJ Werden, KW Evans, JH Taube, TR Sarkar, ...
Cancer research 73 (6), 1981-1992, 2013
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties
JH Taube, GG Malouf, E Lu, N Sphyris, V Vijay, PP Ramachandran, ...
Scientific reports 3 (1), 2687, 2013
GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer
GV Vijay, N Zhao, P Den Hollander, MJ Toneff, R Joseph, M Pietila, ...
Breast Cancer Research 21, 1-14, 2019
GD3 synthase regulates epithelial–mesenchymal transition and metastasis in breast cancer
TR Sarkar, VL Battula, SJ Werden, GV Vijay, EQ Ramirez-Peña, JH Taube, ...
Oncogene 34 (23), 2958-2967, 2015
Foxa1 functions as a pioneer transcription factor at transposable elements to activate Afp during differentiation of embryonic stem cells
JH Taube, K Allton, SA Duncan, L Shen, MC Barton
Journal of Biological Chemistry 285 (21), 16135-16144, 2010
Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition
GG Malouf, JH Taube, Y Lu, T Roysarkar, S Panjarian, MRH Estecio, ...
Genome biology 14, 1-17, 2013
Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein
H Zarkoob, JH Taube, SK Singh, SA Mani, M Kohandel
PloS one 8 (5), e64169, 2013
Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties
AN Paranjape, R Soundararajan, SJ Werden, R Joseph, JH Taube, H Liu, ...
Oncogene 35 (46), 5963-5976, 2016
Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells
H Lujan, WC Griffin, JH Taube, CM Sayes
International journal of nanomedicine, 5159-5173, 2019
The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition
JH Taube, N Sphyris, KS Johnson, KN Reisenauer, TA Nesbit, R Joseph, ...
Oncotarget 8 (39), 65548, 2017
Family members p53 and p73 act together in chromatin modification and direct repression of α-fetoprotein transcription
R Cui, TT Nguyen, JH Taube, SA Stratton, MH Feuerman, MC Barton
Journal of Biological Chemistry 280 (47), 39152-39160, 2005
Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth
SJ Werden, N Sphyris, TR Sarkar, AN Paranjape, AM LaBaff, JH Taube, ...
Oncogene 35 (46), 5977-5988, 2016
Regulating methylation at H3K27: a trick or treat for cancer cell plasticity
P Das, JH Taube
Cancers 12 (10), 2792, 2020
Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia
A Dhawan, SA Madani Tonekaboni, JH Taube, S Hu, N Sphyris, SA Mani, ...
Scientific reports 6 (1), 18074, 2016
Integrative analysis of breast cancer profiles in TCGA by TNBC subgrouping reveals novel microRNA-specific clusters, including miR-17-92a, distinguishing basal-like 1 and basal …
K Kalecky, R Modisette, S Pena, YR Cho, J Taube
BMC cancer 20, 1-13, 2020
Pharmacophore-directed retrosynthesis applied to ophiobolin A: Simplified bicyclic derivatives displaying anticancer activity
Y Tao, KN Reisenauer, M Masi, A Evidente, JH Taube, D Romo
Organic letters 22 (21), 8307-8312, 2020
CTCF expression and dynamic motif accessibility modulates epithelial–mesenchymal gene expression
KS Johnson, S Hussein, P Chakraborty, A Muruganantham, S Mikhail, ...
Cancers 14 (1), 209, 2022
Epithelial-mesenchymal transition sensitizes breast cancer cells to cell death via the fungus-derived sesterterpenoid ophiobolin A
KN Reisenauer, Y Tao, P Das, S Song, H Svatek, SD Patel, S Mikhail, ...
Scientific Reports 11 (1), 10652, 2021
Triterpenoids from the stem bark of Vitellaria paradoxa (Sapotaceae) and derived esters exhibit cytotoxicity against a breast cancer cell line
KO Eyong, G Bairy, AA Eno, J Taube, KG Hull, GN Folefoc, HS Foyet, ...
Medicinal Chemistry Research 27, 268-277, 2018
The system can't perform the operation now. Try again later.
Articles 1–20